Form 8 IRB at Signatory Institution

NIH NCI Central Institutional Review Board (CIRB) Initiative (NCI)

Attachment 2G - IRB_SignatoryInstitution_110110

IRB at Signatory Institution (Attach 2G)

OMB: 0925-0625

Document [pdf]
Download: pdf | pdf
National Cancer Institute
Central IRB Initiative

OMB#: 0925 – xxxx Expiry Date: xx/xx/xxxx
STATEMENT OF CONFIDENTIALITY
Collection of this information is authorized under 42 USC 285a. While your participation is completely voluntary, to
participate in the NCI CIRB, completion of this form is required. Data collected as part of the NCI CIRB review is private
and protected by law. Under the provisions of Section 301d of the Public Health Service Act, no information that could
permit identification of a participating individual may be released. All such information will be kept private under the
Privacy Act and will be presented only in statistical or summary form.
NOTIFICATION TO RESPONDENT OF ESTIMATED BURDEN
Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the
time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and
completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is
not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Send comments regarding this burden estimate or any other aspect of this collection of information, including
suggestions for reducing this burden, to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda,
MD 20892-7974, ATTN: PRA (0925-xxxx*). Do not return the completed form to this address.

IRB at Signatory Institution
(All contact forms must be submitted by the local IRB of the signatory institution.)
Please list IRB(s) at your signatory institution that currently review Pediatric and/or Adult Cooperative Group cancer
treatment studies. Be sure to supply the OHRP IRB Registration Number for each IRB and whether each IRB will
be reviewing Adult or Pediatric Cooperative Group treatment studies or both.
Add
Revise
IRB Information at Signatory Institution
Institution Name
IRB Name
OHRP IRB Registration Number
Review Type (Adult, Pediatric, Both)
Will this IRB have authority to perform facilitated review? (Yes, No)
Is this IRB the IRB of Record for an entire Community Clinical
Name of CCOP
Oncology Program (CCOP)? (Yes/No)
Does this IRB serve as the IRB of Record for a participating
Name of CCOP
CCOP institution? (Yes/No)
Is this IRB the IRB of Record for an entire for a Minority-Based
Name of MBCCOP
Community Clinical Oncology Program (MBCCOP)? (Yes/No)
Does this IRB serve as the IRB of Record for a participating
MBCCOP institution? (Yes/No)
Does this IRB serve as the IRB of record for an NCI-designated
Cancer Center? (Yes/No)
Does this IRB review adult Cooperative Group phase 3 and/or
pediatric phase 2, 3 or pilot studies for a college, university, or
medical school? (Yes/No)
Remove IRB(s)
IRB Name

Name of MBCCOP
Name of Cancer Center
Name of College, University, or Medical School

IRB Registration Number


File Typeapplication/pdf
File TitleAttachment 2G - IRB_SignatoryInstitution_110110.doc
Authorjdugan
File Modified0000-00-00
File Created2010-10-29

© 2024 OMB.report | Privacy Policy